nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—NISCH—Podofilox—Etoposide—muscle cancer	0.0512	0.592	CbGdCrCtD
Guanfacine—Paresis—Vincristine—muscle cancer	0.0368	0.0402	CcSEcCtD
Guanfacine—NISCH—Vinblastine—Vincristine—muscle cancer	0.0352	0.408	CbGdCrCtD
Guanfacine—Testicular disorder—Doxorubicin—muscle cancer	0.0325	0.0356	CcSEcCtD
Guanfacine—Paresis—Methotrexate—muscle cancer	0.0178	0.0195	CcSEcCtD
Guanfacine—Loss of libido—Methotrexate—muscle cancer	0.0141	0.0154	CcSEcCtD
Guanfacine—Retrosternal pain—Doxorubicin—muscle cancer	0.014	0.0153	CcSEcCtD
Guanfacine—Lethargy—Dactinomycin—muscle cancer	0.0111	0.0122	CcSEcCtD
Guanfacine—Skin exfoliation—Etoposide—muscle cancer	0.0104	0.0114	CcSEcCtD
Guanfacine—Liver function test abnormal—Dactinomycin—muscle cancer	0.0101	0.011	CcSEcCtD
Guanfacine—Pain in extremity—Vincristine—muscle cancer	0.00974	0.0107	CcSEcCtD
Guanfacine—Dysphagia—Dactinomycin—muscle cancer	0.00942	0.0103	CcSEcCtD
Guanfacine—Cardiac failure congestive—Etoposide—muscle cancer	0.0087	0.00952	CcSEcCtD
Guanfacine—Hypokinesia—Doxorubicin—muscle cancer	0.00835	0.00914	CcSEcCtD
Guanfacine—Erectile dysfunction—Vincristine—muscle cancer	0.00775	0.00848	CcSEcCtD
Guanfacine—Acute coronary syndrome—Vincristine—muscle cancer	0.0074	0.0081	CcSEcCtD
Guanfacine—Myocardial infarction—Vincristine—muscle cancer	0.00736	0.00805	CcSEcCtD
Guanfacine—Sweating—Vincristine—muscle cancer	0.00719	0.00787	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00696	0.00762	CcSEcCtD
Guanfacine—Dysphagia—Etoposide—muscle cancer	0.00682	0.00746	CcSEcCtD
Guanfacine—Hallucination—Vincristine—muscle cancer	0.0067	0.00734	CcSEcCtD
Guanfacine—Alopecia—Dactinomycin—muscle cancer	0.00666	0.00729	CcSEcCtD
Guanfacine—Skin exfoliation—Methotrexate—muscle cancer	0.00621	0.0068	CcSEcCtD
Guanfacine—Ill-defined disorder—Dactinomycin—muscle cancer	0.00609	0.00667	CcSEcCtD
Guanfacine—Nocturia—Doxorubicin—muscle cancer	0.00608	0.00665	CcSEcCtD
Guanfacine—Acute coronary syndrome—Etoposide—muscle cancer	0.00599	0.00656	CcSEcCtD
Guanfacine—Myocardial infarction—Etoposide—muscle cancer	0.00596	0.00652	CcSEcCtD
Guanfacine—Alopecia—Vincristine—muscle cancer	0.00595	0.00652	CcSEcCtD
Guanfacine—Malaise—Dactinomycin—muscle cancer	0.00592	0.00648	CcSEcCtD
Guanfacine—Atrioventricular block—Doxorubicin—muscle cancer	0.00581	0.00636	CcSEcCtD
Guanfacine—Myalgia—Dactinomycin—muscle cancer	0.00559	0.00612	CcSEcCtD
Guanfacine—Discomfort—Dactinomycin—muscle cancer	0.00552	0.00604	CcSEcCtD
Guanfacine—Agitation—Vincristine—muscle cancer	0.00539	0.0059	CcSEcCtD
Guanfacine—Skin exfoliation—Doxorubicin—muscle cancer	0.00538	0.00589	CcSEcCtD
Guanfacine—Oedema—Dactinomycin—muscle cancer	0.00536	0.00586	CcSEcCtD
Guanfacine—Vertigo—Vincristine—muscle cancer	0.00527	0.00577	CcSEcCtD
Guanfacine—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00518	0.00567	CcSEcCtD
Guanfacine—Renal failure acute—Methotrexate—muscle cancer	0.00512	0.0056	CcSEcCtD
Guanfacine—Eye disorder—Etoposide—muscle cancer	0.0051	0.00558	CcSEcCtD
Guanfacine—Convulsion—Vincristine—muscle cancer	0.00508	0.00556	CcSEcCtD
Guanfacine—Hypertension—Vincristine—muscle cancer	0.00506	0.00554	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00501	0.00548	CcSEcCtD
Guanfacine—Myalgia—Vincristine—muscle cancer	0.00499	0.00546	CcSEcCtD
Guanfacine—Immune system disorder—Etoposide—muscle cancer	0.00493	0.0054	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00488	0.00534	CcSEcCtD
Guanfacine—Alopecia—Etoposide—muscle cancer	0.00482	0.00528	CcSEcCtD
Guanfacine—Cerebrovascular accident—Methotrexate—muscle cancer	0.00482	0.00528	CcSEcCtD
Guanfacine—Lethargy—Methotrexate—muscle cancer	0.00482	0.00528	CcSEcCtD
Guanfacine—Oedema—Vincristine—muscle cancer	0.00479	0.00524	CcSEcCtD
Guanfacine—Decreased appetite—Dactinomycin—muscle cancer	0.00466	0.0051	CcSEcCtD
Guanfacine—Dysgeusia—Etoposide—muscle cancer	0.00465	0.00509	CcSEcCtD
Guanfacine—Hyperhidrosis—Vincristine—muscle cancer	0.00463	0.00506	CcSEcCtD
Guanfacine—Fatigue—Dactinomycin—muscle cancer	0.00462	0.00506	CcSEcCtD
Guanfacine—Vascular purpura—Doxorubicin—muscle cancer	0.00457	0.00501	CcSEcCtD
Guanfacine—Muscle spasms—Etoposide—muscle cancer	0.00457	0.005	CcSEcCtD
Guanfacine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00451	0.00494	CcSEcCtD
Guanfacine—Irritability—Methotrexate—muscle cancer	0.00451	0.00494	CcSEcCtD
Guanfacine—Hypotension—Vincristine—muscle cancer	0.00447	0.0049	CcSEcCtD
Guanfacine—Renal failure acute—Doxorubicin—muscle cancer	0.00443	0.00485	CcSEcCtD
Guanfacine—Feeling abnormal—Dactinomycin—muscle cancer	0.00441	0.00483	CcSEcCtD
Guanfacine—Ill-defined disorder—Etoposide—muscle cancer	0.00441	0.00482	CcSEcCtD
Guanfacine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00438	0.00479	CcSEcCtD
Guanfacine—Liver function test abnormal—Methotrexate—muscle cancer	0.00436	0.00477	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00436	0.00477	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00434	0.00475	CcSEcCtD
Guanfacine—Insomnia—Vincristine—muscle cancer	0.00433	0.00474	CcSEcCtD
Guanfacine—Paraesthesia—Vincristine—muscle cancer	0.0043	0.0047	CcSEcCtD
Guanfacine—Malaise—Etoposide—muscle cancer	0.00428	0.00469	CcSEcCtD
Guanfacine—Vertigo—Etoposide—muscle cancer	0.00427	0.00467	CcSEcCtD
Guanfacine—Purpura—Doxorubicin—muscle cancer	0.00424	0.00465	CcSEcCtD
Guanfacine—Abdominal pain—Dactinomycin—muscle cancer	0.00423	0.00464	CcSEcCtD
Guanfacine—Loss of consciousness—Etoposide—muscle cancer	0.00418	0.00457	CcSEcCtD
Guanfacine—Lethargy—Doxorubicin—muscle cancer	0.00418	0.00457	CcSEcCtD
Guanfacine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00418	0.00457	CcSEcCtD
Guanfacine—Decreased appetite—Vincristine—muscle cancer	0.00416	0.00455	CcSEcCtD
Guanfacine—Fatigue—Vincristine—muscle cancer	0.00413	0.00452	CcSEcCtD
Guanfacine—Convulsion—Etoposide—muscle cancer	0.00412	0.00451	CcSEcCtD
Guanfacine—Hypertension—Etoposide—muscle cancer	0.0041	0.00449	CcSEcCtD
Guanfacine—Constipation—Vincristine—muscle cancer	0.00409	0.00448	CcSEcCtD
Guanfacine—Pain in extremity—Doxorubicin—muscle cancer	0.00409	0.00448	CcSEcCtD
Guanfacine—Asthma—Methotrexate—muscle cancer	0.00408	0.00447	CcSEcCtD
Guanfacine—Chest pain—Etoposide—muscle cancer	0.00404	0.00443	CcSEcCtD
Guanfacine—Affect lability—Doxorubicin—muscle cancer	0.00403	0.00441	CcSEcCtD
Guanfacine—Discomfort—Etoposide—muscle cancer	0.004	0.00437	CcSEcCtD
Guanfacine—Hypersensitivity—Dactinomycin—muscle cancer	0.00395	0.00432	CcSEcCtD
Guanfacine—Abdominal discomfort—Methotrexate—muscle cancer	0.00392	0.00429	CcSEcCtD
Guanfacine—Gastrointestinal pain—Vincristine—muscle cancer	0.00391	0.00428	CcSEcCtD
Guanfacine—Confusional state—Etoposide—muscle cancer	0.00391	0.00428	CcSEcCtD
Guanfacine—Asthenia—Dactinomycin—muscle cancer	0.00384	0.00421	CcSEcCtD
Guanfacine—Tachycardia—Etoposide—muscle cancer	0.00378	0.00414	CcSEcCtD
Guanfacine—Abdominal pain—Vincristine—muscle cancer	0.00378	0.00414	CcSEcCtD
Guanfacine—Liver function test abnormal—Doxorubicin—muscle cancer	0.00378	0.00413	CcSEcCtD
Guanfacine—Erectile dysfunction—Methotrexate—muscle cancer	0.00376	0.00412	CcSEcCtD
Guanfacine—Hyperhidrosis—Etoposide—muscle cancer	0.00375	0.0041	CcSEcCtD
Guanfacine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00374	0.00409	CcSEcCtD
Guanfacine—Abdominal pain upper—Doxorubicin—muscle cancer	0.00374	0.00409	CcSEcCtD
Guanfacine—Diarrhoea—Dactinomycin—muscle cancer	0.00367	0.00401	CcSEcCtD
Guanfacine—Drowsiness—Methotrexate—muscle cancer	0.00364	0.00399	CcSEcCtD
Guanfacine—Hypotension—Etoposide—muscle cancer	0.00362	0.00397	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00361	0.00395	CcSEcCtD
Guanfacine—Conjunctivitis—Methotrexate—muscle cancer	0.00354	0.00387	CcSEcCtD
Guanfacine—Asthma—Doxorubicin—muscle cancer	0.00354	0.00387	CcSEcCtD
Guanfacine—Dysphagia—Doxorubicin—muscle cancer	0.00354	0.00387	CcSEcCtD
Guanfacine—Hypersensitivity—Vincristine—muscle cancer	0.00353	0.00386	CcSEcCtD
Guanfacine—Sweating—Methotrexate—muscle cancer	0.00349	0.00382	CcSEcCtD
Guanfacine—Paraesthesia—Etoposide—muscle cancer	0.00348	0.00381	CcSEcCtD
Guanfacine—Dyspnoea—Etoposide—muscle cancer	0.00346	0.00378	CcSEcCtD
Guanfacine—Somnolence—Etoposide—muscle cancer	0.00345	0.00377	CcSEcCtD
Guanfacine—Asthenia—Vincristine—muscle cancer	0.00343	0.00376	CcSEcCtD
Guanfacine—Vomiting—Dactinomycin—muscle cancer	0.00341	0.00373	CcSEcCtD
Guanfacine—Rash—Dactinomycin—muscle cancer	0.00338	0.0037	CcSEcCtD
Guanfacine—Decreased appetite—Etoposide—muscle cancer	0.00337	0.00369	CcSEcCtD
Guanfacine—Fatigue—Etoposide—muscle cancer	0.00334	0.00366	CcSEcCtD
Guanfacine—Constipation—Etoposide—muscle cancer	0.00332	0.00363	CcSEcCtD
Guanfacine—Diarrhoea—Vincristine—muscle cancer	0.00327	0.00358	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—muscle cancer	0.00327	0.00358	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—muscle cancer	0.00322	0.00352	CcSEcCtD
Guanfacine—Feeling abnormal—Etoposide—muscle cancer	0.00319	0.0035	CcSEcCtD
Guanfacine—Nausea—Dactinomycin—muscle cancer	0.00318	0.00348	CcSEcCtD
Guanfacine—Gastrointestinal pain—Etoposide—muscle cancer	0.00317	0.00347	CcSEcCtD
Guanfacine—Dizziness—Vincristine—muscle cancer	0.00316	0.00346	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—muscle cancer	0.00315	0.00345	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—muscle cancer	0.00315	0.00345	CcSEcCtD
Guanfacine—Abdominal pain—Etoposide—muscle cancer	0.00306	0.00335	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—muscle cancer	0.00306	0.00335	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—muscle cancer	0.00305	0.00334	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—muscle cancer	0.00305	0.00334	CcSEcCtD
Guanfacine—Vomiting—Vincristine—muscle cancer	0.00304	0.00333	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—muscle cancer	0.00302	0.00331	CcSEcCtD
Guanfacine—Rash—Vincristine—muscle cancer	0.00302	0.0033	CcSEcCtD
Guanfacine—Dermatitis—Vincristine—muscle cancer	0.00301	0.0033	CcSEcCtD
Guanfacine—Headache—Vincristine—muscle cancer	0.003	0.00328	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—muscle cancer	0.00295	0.00323	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—muscle cancer	0.00289	0.00316	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—muscle cancer	0.00288	0.00315	CcSEcCtD
Guanfacine—Hypersensitivity—Etoposide—muscle cancer	0.00286	0.00313	CcSEcCtD
Guanfacine—Nausea—Vincristine—muscle cancer	0.00284	0.00311	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—muscle cancer	0.00284	0.00311	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—muscle cancer	0.00279	0.00305	CcSEcCtD
Guanfacine—Asthenia—Etoposide—muscle cancer	0.00278	0.00304	CcSEcCtD
Guanfacine—Pruritus—Etoposide—muscle cancer	0.00274	0.003	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—muscle cancer	0.00273	0.00299	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—muscle cancer	0.00268	0.00294	CcSEcCtD
Guanfacine—Diarrhoea—Etoposide—muscle cancer	0.00265	0.0029	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—muscle cancer	0.00265	0.0029	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—muscle cancer	0.00264	0.00289	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—muscle cancer	0.00264	0.00289	CcSEcCtD
Guanfacine—Malaise—Methotrexate—muscle cancer	0.00257	0.00281	CcSEcCtD
Guanfacine—Dizziness—Etoposide—muscle cancer	0.00256	0.00281	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—muscle cancer	0.00256	0.0028	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—muscle cancer	0.00256	0.0028	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—muscle cancer	0.0025	0.00274	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—muscle cancer	0.00247	0.0027	CcSEcCtD
Guanfacine—Vomiting—Etoposide—muscle cancer	0.00247	0.0027	CcSEcCtD
Guanfacine—Rash—Etoposide—muscle cancer	0.00244	0.00268	CcSEcCtD
Guanfacine—Dermatitis—Etoposide—muscle cancer	0.00244	0.00267	CcSEcCtD
Guanfacine—Headache—Etoposide—muscle cancer	0.00243	0.00266	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—muscle cancer	0.00242	0.00265	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—muscle cancer	0.00242	0.00265	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—muscle cancer	0.00242	0.00265	CcSEcCtD
Guanfacine—Tension—Doxorubicin—muscle cancer	0.00242	0.00265	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—muscle cancer	0.00241	0.00264	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—muscle cancer	0.00239	0.00262	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—muscle cancer	0.00239	0.00262	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—muscle cancer	0.00237	0.00259	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—muscle cancer	0.00234	0.00256	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—muscle cancer	0.00232	0.00254	CcSEcCtD
Guanfacine—Nausea—Etoposide—muscle cancer	0.0023	0.00252	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—muscle cancer	0.00229	0.0025	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—muscle cancer	0.00226	0.00248	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—muscle cancer	0.00225	0.00246	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—muscle cancer	0.00222	0.00243	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—muscle cancer	0.00221	0.00242	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—muscle cancer	0.00221	0.00242	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—muscle cancer	0.00218	0.00238	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—muscle cancer	0.00217	0.00238	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—muscle cancer	0.00217	0.00237	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—muscle cancer	0.00213	0.00234	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—muscle cancer	0.00213	0.00233	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00212	0.00232	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—muscle cancer	0.0021	0.0023	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—muscle cancer	0.0021	0.0023	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—muscle cancer	0.0021	0.0023	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—muscle cancer	0.0021	0.0023	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—muscle cancer	0.00209	0.00229	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—muscle cancer	0.00209	0.00228	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—muscle cancer	0.00207	0.00227	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—muscle cancer	0.00207	0.00227	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—muscle cancer	0.00206	0.00226	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—muscle cancer	0.00205	0.00225	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—muscle cancer	0.00204	0.00224	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—muscle cancer	0.00203	0.00222	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—muscle cancer	0.00202	0.00221	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—muscle cancer	0.00201	0.0022	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—muscle cancer	0.002	0.00219	CcSEcCtD
Guanfacine—Shock—Doxorubicin—muscle cancer	0.00198	0.00217	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—muscle cancer	0.00196	0.00215	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00194	0.00213	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—muscle cancer	0.00191	0.00209	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—muscle cancer	0.0019	0.00208	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—muscle cancer	0.00188	0.00206	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—muscle cancer	0.00184	0.00201	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00183	0.00201	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—muscle cancer	0.00182	0.00199	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—muscle cancer	0.00181	0.00198	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—muscle cancer	0.00179	0.00196	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—muscle cancer	0.00179	0.00196	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—muscle cancer	0.00177	0.00194	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—muscle cancer	0.00175	0.00191	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—muscle cancer	0.00173	0.0019	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—muscle cancer	0.00172	0.00188	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—muscle cancer	0.00171	0.00187	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—muscle cancer	0.00167	0.00182	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—muscle cancer	0.00166	0.00181	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00164	0.0018	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—muscle cancer	0.00164	0.0018	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—muscle cancer	0.00159	0.00174	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—muscle cancer	0.00159	0.00174	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—muscle cancer	0.00154	0.00168	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—muscle cancer	0.00148	0.00162	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—muscle cancer	0.00148	0.00162	CcSEcCtD
Guanfacine—Rash—Methotrexate—muscle cancer	0.00146	0.0016	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—muscle cancer	0.00146	0.0016	CcSEcCtD
Guanfacine—Headache—Methotrexate—muscle cancer	0.00145	0.00159	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—muscle cancer	0.00144	0.00158	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—muscle cancer	0.00142	0.00156	CcSEcCtD
Guanfacine—Nausea—Methotrexate—muscle cancer	0.00138	0.00151	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—muscle cancer	0.00138	0.00151	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—muscle cancer	0.00133	0.00146	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—muscle cancer	0.00128	0.0014	CcSEcCtD
Guanfacine—Rash—Doxorubicin—muscle cancer	0.00127	0.00139	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—muscle cancer	0.00127	0.00139	CcSEcCtD
Guanfacine—Headache—Doxorubicin—muscle cancer	0.00126	0.00138	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—muscle cancer	0.00119	0.00131	CcSEcCtD
